Motoyama Kazuo, Inoue Hiroshi, Takatsuno Yasushi, Tanaka Fumiaki, Mimori Koshi, Uetake Hiroyuki, Sugihara Kenichi, Mori Masaki
Department of Molecular and Surgical Oncology, Medical Institute of Bioregulation, Kyushu University, Beppu 874-0838, Japan.
Int J Oncol. 2009 Apr;34(4):1069-75. doi: 10.3892/ijo_00000233.
MicroRNAs (miRNAs) constitute a class of small (21-23 nucleotides) noncoding RNAs that function as post-transcriptional gene regulators. It is becoming increasingly clear that altered miRNA expression correlates with the pathogenesis of cancers. The purpose of this study was to determine the up-regulated miRNAs in human colorectal cancer. Total RNA was isolated from cancer tissues and corresponding noncancerous tissues from surgically resected colorectal cancers. The expression profiles of miRNAs were determined using a miRNA microarray containing 455 human miRNA probes. The expression status of selected miRNAs in paired clinical samples was then investigated by real-time RT-PCR. Twenty-one miRNAs were identified by miRNA array analysis as overexpressed in colorectal cancer tissues compared to normal epithelial tissues. Among them, the expression of miR-31, miR-183, miR-17-5p, miR-18a, miR-20a and miR-92 were confirmed to be significantly higher in cancer tissues than in normal tissues (P<0.05). In contrast, the expression of miR-143 and miR-145 in cancer tissues were significantly lower than in normal tissues (P<0.05). The miR-18a overexpression group tended to have a poorer clinical prognosis than the low expression group (P=0.07). We identified miRNAs that were overexpressed or under-expressed in colorectal cancers and which may be correlated with colorectal carcinogenesis.
微小RNA(miRNA)是一类小的(21 - 23个核苷酸)非编码RNA,其作为转录后基因调节因子发挥作用。越来越清楚的是,miRNA表达改变与癌症的发病机制相关。本研究的目的是确定人类结直肠癌中上调的miRNA。从手术切除的结直肠癌的癌组织和相应的非癌组织中分离总RNA。使用包含455个人类miRNA探针的miRNA微阵列确定miRNA的表达谱。然后通过实时RT-PCR研究配对临床样本中所选miRNA的表达状态。通过miRNA阵列分析鉴定出21种miRNA在结直肠癌组织中比正常上皮组织中过表达。其中,miR-31、miR-183、miR-17-5p、miR-18a、miR-20a和miR-92在癌组织中的表达被证实明显高于正常组织(P<0.05)。相反,miR-143和miR-145在癌组织中的表达明显低于正常组织(P<0.05)。miR-18a过表达组的临床预后往往比低表达组差(P = 0.07)。我们鉴定出在结直肠癌中过表达或低表达且可能与结直肠癌发生相关的miRNA。